Decreased COVID Antibody Response in MS Patients Taking Ocrelizumab ...Middle East

Medscape - News
Antibody, but not T-cell, response appears to be attenuated in patients with MS who take the disease-modifying therapy ocrelizumab during COVID-19 infection, new research shows. Medscape Medical News

Hence then, the article about decreased covid antibody response in ms patients taking ocrelizumab was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Decreased COVID Antibody Response in MS Patients Taking Ocrelizumab )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News